FDA Inspection 888838 — Center For Advanced Reproductive Endocrinology

Center For Advanced Reproductive Endocrinology — FEI 3004586714

The FDA completed an inspection of Center For Advanced Reproductive Endocrinology on Jul 25, 2014 in Plantation, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 25, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Plantation, FL (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223021 CFR 1271.50(a)Responsible person to determine, document
1223121 CFR 1271.50(b)(1)Donor screening standards
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1228221 CFR 1271.75(d)Donors with risks not determined ineligible